Search | IOVS | ARVO Journals

Showing 1 – 20 of 75

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Neural plasticity of the human visual system reflects treatment effect in gene therapy for Achromatopsia

Immanuel Philipp Seitz; Michael Erb; Thomas Ethofer; Andriani Rina; Georgios Keliris; M Dominik Fischer; Karl-Ulrich Bartz-Schmidt

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):452. doi:

Articles July 2021

CT Assessment of Intraorbital Cable Movement of Electronic Subretinal Prosthesis in Three Different Surgical Approaches

PDF

Hanna Faber; Ulrike Ernemann; Helmut Sachs; Florian Gekeler; Søren Danz; Assen Koitschev; Dorothea Besch; Karl-Ulrich Bartz-Schmidt; Eberhart Zrenner; Katarina Stingl; Christoph Kernstock
TAGS: implants, prostheses, surgical procedures, operative, retina, eye movement
Trans. Vis. Sci. Tech.. 2021; 10(8):16. doi: https://doi.org/10.1167/tvst.10.8.16

Includes: Multimedia, Supplemental Content

ARVO Annual Meeting Abstract July 2019

Outcomes after Descemet Membrane Endothelial Keratoplasty (DMEK) in a German multicenter study

Klara Charlotte Borgardts; Kristina Spaniol; Björn Bachmann; Martin Hellmich; Gerd Geerling; Philip Maier; Peter MH Wiedemann; Karl Ulrich Bartz-Schmidt; Max Pattmoeller; Anna-Karina Maier-Wenzel

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2224. doi:

ARVO Annual Meeting Abstract July 2019

Effects of Subretinal AAV8 Gene Therapy on Microperimetry in CNGA3 Achromatopsia Patients

G. Alex Ochakovski; Ahmad Zhour; Laura Kuehlewein; Susanne Kohl; Andrea Rindtorff; Karl Ulrich Bartz-Schmidt; Marius Ueffing; Eberhart Zrenner; Stylianos Michalakis; Martin Biel; Bernd Wissinger; Tobias Peters; Barbara Wilhelm; M. Dominik Fischer

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2921. doi:

ARVO Annual Meeting Abstract July 2019

Descemet’s Membrane Endothelial Keratoplasty: Long-term development of color and contrast in Fuchs' endothelial corneal dystrophy patients

Tarek Bayyoud; Helmut Wilhelm; Manfred Zierhut; Sebastian Thaler; Karl Ulrich Bartz-Schmidt

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3812. doi:

ARVO Annual Meeting Abstract July 2019

Potential therapy of neurodegenerative retinopathies via activation of the BDNF-TrkB signaling pathway by a specific aptamer

Marina Löscher; Evangelia Lilou; Karl Ulrich Bartz-Schmidt; Sven Schnichels; José Hurst

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5708. doi:

ARVO Annual Meeting Abstract July 2019

Evaluation of pupil responses to local stimuli in Patients with retinitis pigmentosa caused by USH2A mutations

Tobias Peters; Krunoslav Stingl; Karl Ulrich Bartz-Schmidt; Laura Kuehlewein; Carina Kelbsch; Melanie Kempf; Eberhart Zrenner; Barbara Wilhelm; Katarina Stingl

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1829. doi:

ARVO Annual Meeting Abstract July 2018

Retinal ganglion cells are protected through hypothermia treatment in an organ culture model

Jose Hurst; Sandra Kuehn; Ana Maliha; Fenja Herms; H Burkhard Dick; Karl Ulrich Bartz-Schmidt; Sven Schnichels; Stephanie C Joachim

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5501. doi:

ARVO Annual Meeting Abstract July 2018

DNA Nanoparticles for the Treatment of Retinal Diseases: in-vivo results

Sven Schnichels; David Simmang; Lisa Strudel; Jose Hurst; Jan Willem de Vries; Karl Ulrich Bartz-Schmidt; Andreas Herrmann; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5683. doi:

ARVO Annual Meeting Abstract July 2018

Lipid DNA Nanoparticles – a versatile vehicle for anterior segment drug delivery

Lisa Strudel; Jose Hurst; Jan Willem de Vries; Agnieszka Gruszka; Karl Ulrich Bartz-Schmidt; Andreas Herrmann; Martin Stephan Spitzer; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5684. doi:

ARVO Annual Meeting Abstract July 2018

First Gene Supplementation Therapy for CNGA3-linked Achromatopsia

M Dominik Fischer; Stylianos Michalakis; Barbara Wilhelm; Nadine Kahle; Tobias Peters; Karl Ulrich Bartz-Schmidt; Susanne Kohl; Mathias W Seeliger; Nicole Weisschuh; Ditta Zobor; Eberhart Zrenner; Marius Ueffing; Martin Biel; Bernd Wissinger

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2982. doi:

ARVO Annual Meeting Abstract July 2018

Changes in Microchip Position after Implantation of a Subretinal Vision Prosthesis in Humans

Laura Kuehlewein; Nicole Troelenberg; Krunoslav Stingl; Sebastian Schleehauf; Akos Kusnyerik; Helmut Sachs; Johann Roider; Timothy L Jackson; Robert E MacLaren; Caroline Chee; Barbara Wilhelm; Florian Gekeler; Karl Ulrich Bartz-Schmidt; Eberhart Zrenner; Katarina Stingl

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4561. doi:

ARVO Annual Meeting Abstract July 2018

Safety study in cynomolgus monkeys after subretinal injection of rAAV.hPDE6A

Tobias Peters; Barbara Wilhelm; Birgit Korbmacher; Sven Korte; Karl Ulrich Bartz-Schmidt; Stylianos Michalakis; Guy Alex Ochakovski; M Dominik Fischer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2658. doi:

ARVO Annual Meeting Abstract June 2017

Establishment Of A Porcine Corneal Endothelial Organ Culture Model

Maximilian Schultheiss; Berenike Kunzmann; Christian Klameth; Karl-Ulrich Bartz-Schmidt; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1464. doi:

ARVO Annual Meeting Abstract June 2017

Evaluation of electroretinography in cynomolgus monkeys after subretinal injection of rAAV.hPDE6A

Tobias Peters; Barbara Wilhelm; birgit niggemann; Sven Korte; Karl Ulrich Bartz-Schmidt; Stylianos Michalakis; Guy Alex Ochakovski; Dominik M Fischer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4096. doi:

ARVO Annual Meeting Abstract June 2017

Travoprost loaded lipid DNA-nanoparticles as a new and improved treatment for glaucoma

Sven Schnichels; Jan Willem de Vries; Agnieszka Gruszka; Karl Ulrich Bartz-Schmidt; Sascha Dammeier; Andreas Herrmann; Martin Stephan Spitzer; Jose Hurst

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4105. doi:

ARVO Annual Meeting Abstract June 2017

Lipid modified aptamers as vehicles for ophthalmic drug delivery

Lisa Strudel; Jose Hurst; Agnieszka Gruszka; Ullrich Hagel; Jan Willem de Vries; Karl Ulrich Bartz-Schmidt; Andreas Herrmann; Martin Stephan Spitzer; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4107. doi:

ARVO Annual Meeting Abstract June 2017

Results from a Multicenter Trial with the New Electronic Subretinal Implant Alpha AMS in 15 Patients Blind from Inherired Retinal Dystrophies (RD)

Eberhart Zrenner; Karl-Ulrich Bartz-Schmidt; Charles L Cottriall; Thomas Edwards; Florian Gekeler; Udo Greppmaier; Laura Kuehlewein; Robert E MacLaren; James Ramsden; Johann Roider; Helmut G Sachs; Ruth Schippert; Jan Tode; Nicole Troelenberg; Katarina Stingl

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4266. doi:

ARVO Annual Meeting Abstract June 2017

How do patients rate their subjective symptoms after CNGA3 gene therapy: First application of the instrument A3-PRO

Barbara Wilhelm; Andreas Koegel; Nadine Kahle; Tobias Peters; Stylianos Michalakis; Martin Biel; Mathias Seeliger; Eberhart Zrenner; Bernd Wissinger; Susanne Kohl; Marius Ueffing; Karl Ulrich Bartz-Schmidt; Dominik M Fischer; Ditta Zobor

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4678. doi:

ARVO Annual Meeting Abstract June 2017

Degenerative effects of cobalt-chloride treatment on neurons and microglia in a porcine retina organ culture model

Jose Hurst; Sandra Kuehn; Farina Rensinghoff; Teresa Tsai; Yathavan Satgunarajah; Karl Ulrich Bartz-Schmidt; Burkhard Dick; Stephanie C Joachim; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):284. doi:

1 2 3 4

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Neural plasticity of the human visual system reflects treatment effect in gene therapy for Achromatopsia

CT Assessment of Intraorbital Cable Movement of Electronic Subretinal Prosthesis in Three Different Surgical Approaches

Outcomes after Descemet Membrane Endothelial Keratoplasty (DMEK) in a German multicenter study

Effects of Subretinal AAV8 Gene Therapy on Microperimetry in CNGA3 Achromatopsia Patients

Descemet’s Membrane Endothelial Keratoplasty: Long-term development of color and contrast in Fuchs' endothelial corneal dystrophy patients

Potential therapy of neurodegenerative retinopathies via activation of the BDNF-TrkB signaling pathway by a specific aptamer

Evaluation of pupil responses to local stimuli in Patients with retinitis pigmentosa caused by USH2A mutations

Retinal ganglion cells are protected through hypothermia treatment in an organ culture model

DNA Nanoparticles for the Treatment of Retinal Diseases: in-vivo results

Lipid DNA Nanoparticles – a versatile vehicle for anterior segment drug delivery

First Gene Supplementation Therapy for CNGA3-linked Achromatopsia

Changes in Microchip Position after Implantation of a Subretinal Vision Prosthesis in Humans

Safety study in cynomolgus monkeys after subretinal injection of rAAV.hPDE6A

Establishment Of A Porcine Corneal Endothelial Organ Culture Model

Evaluation of electroretinography in cynomolgus monkeys after subretinal injection of rAAV.hPDE6A

Travoprost loaded lipid DNA-nanoparticles as a new and improved treatment for glaucoma

Lipid modified aptamers as vehicles for ophthalmic drug delivery

Results from a Multicenter Trial with the New Electronic Subretinal Implant Alpha AMS in 15 Patients Blind from Inherired Retinal Dystrophies (RD)

How do patients rate their subjective symptoms after CNGA3 gene therapy: First application of the instrument A3-PRO

Degenerative effects of cobalt-chloride treatment on neurons and microglia in a porcine retina organ culture model

To View More...

You must be signed into an individual account to use this feature.